Stock listing
Vir Biotechnology, Inc.
Selected listing: VIR · NASDAQ · USD · US
Vir Biotechnology, Inc. (NASDAQ:VIR), Health Technology. Latest release Oct 5, 2026: Vir Biotechnology to Present Expanded Phase 2 SOLSTICE Results…
- Ticker
- NASDAQ:VIR
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Vir Biotechnology, Inc.
Vir Biotechnology, Inc. is a public company traded under the ticker VIR in the American market. Vir focuses on developing innovative therapies for infectious diseases and has a commitment to advancing its scientific research and product pipeline.
Latest news from Vir Biotechnology, Inc.
Vir Biotechnology to Present Expanded Phase 2 SOLSTICE Results for Elebsiran and Tobevibart in Hepatitis Delta at AASLD’s The Liver Meeting® 2026
October 5, 2026
Vir Biotechnology to Present Expanded Phase 2 SOLSTICE Results for Elebsiran and Tobevibart in Hepatitis Delta at AASLD’s The Liver Meeting® 2026
October 4, 2026
Vir Biotechnology Appoints Aziz Sawaf as Chief Financial Officer
October 1, 2026
Vir Biotechnology Appoints Aziz Sawaf as Chief Financial Officer
September 30, 2026
Vir Biotechnology to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
August 31, 2026
Events
Research Vir Biotechnology, Inc.
Vir Biotechnology, Inc. company profile
View the public company page for Vir Biotechnology, Inc. on 6ix.
Vir Biotechnology, Inc. news
Read company news and market updates connected to Vir Biotechnology, Inc..
Vir Biotechnology, Inc. investor events
Find investor webinars, events, and replay context for Vir Biotechnology, Inc..
Alternate listings
VIR:BMV
MX · MXN
Alternate listing for Vir Biotechnology, Inc.; the primary context on this page is VIR:NASDAQ.
VIR:BIVA
MX · MXN
Alternate listing for Vir Biotechnology, Inc.; the primary context on this page is VIR:NASDAQ.
VIR:BX
CH · CHF
Alternate listing for Vir Biotechnology, Inc.; the primary context on this page is VIR:NASDAQ.
VIR:BOATS
US · USD
Alternate listing for Vir Biotechnology, Inc.; the primary context on this page is VIR:NASDAQ.